June 03, 2022, NeoGenomics Inc. (NASDAQ: NEO) trading session started at the price of $8.65, that was -6.92% drop from the session before. During the day, the shares moved up to $8.65 and dropped to $7.94 before settling in for the closing price of $8.67. A 52-week range for NEO has been $7.26 – $54.74.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Annual sales at Healthcare sector company grew by 15.90% over the past five years. When this article was written, the company’s average yearly earnings per share was at -286.40%. With a float of $121.06 million, this company’s outstanding shares have now reached $123.63 million.
Let’s look at the performance matrix of the company that is accounted for 2000 employees. In terms of profitability, gross margin is +37.08, operating margin of -19.66, and the pretax margin is -3.11.
NeoGenomics Inc. (NEO) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward NeoGenomics Inc. stocks. The insider ownership of NeoGenomics Inc. is 1.10%, while institutional ownership is 91.90%. The most recent insider transaction that took place on Mar 07, was worth 58,693. In this transaction Chief Financial Officer of this company sold 3,209 shares at a rate of $18.29, taking the stock ownership to the 98,516 shares. Before that another transaction happened on Dec 21, when Company’s Chief Financial Officer sold 1,846 for $35.00, making the entire transaction worth $64,610. This insider now owns 11,689 shares in total.
NeoGenomics Inc. (NEO) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 3/30/2022, it has been observed that the corporation posted -$0.2 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.23) by $0.03. This company achieved a net margin of -1.72 while generating a return on equity of -0.93. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -286.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.30% during the next five years compared to 29.40% growth over the previous five years of trading.
NeoGenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
You can see what NeoGenomics Inc. (NEO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of NeoGenomics Inc. (NEO)
NeoGenomics Inc. (NASDAQ: NEO) saw its 5-day average volume 1.86 million, a negative change from its year-to-date volume of 1.92 million. As of the previous 9 days, the stock’s Stochastic %D was 42.34%. Additionally, its Average True Range was 0.80.
During the past 100 days, NeoGenomics Inc.’s (NEO) raw stochastic average was set at 3.82%, which indicates a significant decrease from 20.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.77% in the past 14 days, which was lower than the 106.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.74, while its 200-day Moving Average is $28.54. Nevertheless, the first resistance level for the watch stands at $8.50 in the near term. At $8.93, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.21. If the price goes on to break the first support level at $7.79, it is likely to go to the next support level at $7.51. Assuming the price breaks the second support level, the third support level stands at $7.08.
NeoGenomics Inc. (NASDAQ: NEO) Key Stats
There are 124,758K outstanding shares of the company, which has a market capitalization of 1.08 billion. As of now, sales total 484,330 K while income totals -8,350 K. Its latest quarter income was 117,170 K while its last quarter net income were -49,410 K.